SLGL

Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)

About Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high

$0.61

Daily low

$0.52

Price at open

$0.55

52 Week High

$1.65

52 Week Low

$0.33

Market cap

14.5M

Dividend yield

0.00%

Volume

5,886

Avg. volume

37,356

P/E ratio

-1.51

Sol-Gel Technologies Ltd. Ordinary Shares News